With 0.77 million shares changed hands, the volume of the stock remained lighter than its average volume of 1.93 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $4.05 whereas the lowest price it dropped to was $3.51. The 52-week range on DOMH shows that it touched its highest point at $13.05 and its lowest point at $0.79 during that stretch. It currently has a 1-year price target of $16.00. DOMH paid its most recent dividend on 1740355200, while the ex-dividend date for that was 1740355200. Beta for the stock currently stands at 0.88.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of DOMH was down-trending over the past week, with a drop of -28.04%, but this was down by -40.46% over a month. Three-month performance surged to 252.90% while six-month performance rose 121.16%. The stock gained 65.65% in the past year, while it has gained 312.27% so far this year.
Float and Shares Shorts:
At present, 14.39 million DOMH shares are outstanding with a float of 6.74 million shares on hand for trading. On 2025-03-14, short shares totaled 0.28 million, which was 195.0 higher than short shares on 1739491200. In addition to Mr. Anthony C. Hayes Esq. as the firm’s CEO & Chairman, Mr. Kyle Michael Wool serves as its President & Director.
Institutional Ownership:
Through their ownership of 0.0334 of DOMH’s outstanding shares, institutional investors have minority control over the company.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2024-09-30, DOMH reported revenue of $4043000.0 and operating income of -$3196000.0. The EBITDA in the recently reported quarter was -$1776000.0 and diluted EPS was -$0.67.
Analysts Ratings:
In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$2.21 being high and -$2.21 being low. For DOMH, this leads to a yearly average estimate of -$2.21.
